(Q43619959)

25 November 2017

Entactin-induced inhibition of human amyloid beta-protein fibril formation in vitro (English)

1 reference

25 November 2017

Kiuchi Y

1

1 reference

25 November 2017

Isobe Y

series ordinal

2

1 reference

25 November 2017

Fukushima K

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

25 November 2017

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

25 November 2017

305

1 reference

25 November 2017

119-122

1 reference

25 November 2017

2

1 reference

Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Laminin inhibits amyloid-beta-peptide fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Laminin inhibits A beta 40 fibril formation promoted by apolipoprotein E4 in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Association between vascular basement membrane components and the lesions of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901831-6

7 January 2021

10.1016/S0304-3940(01)01831-6

Identifiers

DOI

1 reference

release_mkjm2kne5vgupforhwvosrlaci

25 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mkjm2kne5vgupforhwvosrlaci

24 November 2022

mapped directly with Wikidata item

1 reference